
Julian Mackay-Wiggan MD (She/Her)
Professor, New York University-Langone Health Former Dermatologist, Siperstein Dermatology Former Associate Professor, Dermatology, Columbia University College of Physicians & Surgeons Medical consultant
Join to View Full Profile
101 N Clematis StSuite 110West Palm Beach, FL 33401
Phone+1 561-365-3000
Dr. Mackay-Wiggan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dermatology and Research Consultant
Education & Training
- Columbia University School of Public HealthMS, Patient Oriented Research, 2002 - 2004
- New York Presbyterian Hospital (Columbia Campus)Residency, Dermatology, 1999 - 2002
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1998 - 1999
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
- FL State Medical License 2017 - 2027
- NY State Medical License 2002 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails Start of enrollment: 2005 Aug 01
- Open Label Pilot Study of Apremilast in Treatment of Rosacea Start of enrollment: 2010 Jun 01
- Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsDevelopment of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.Brett A. King, Natasha Atanaskova Mesinkovska, Brittany G. Craiglow, Chesahna Kindred, Justin M. Ko
Journal of the American Academy of Dermatology. 2021-08-30 - 11 citationsAn open-label study evaluating the efficacy of abatacept in alopecia areata.Julian Mackay-Wiggan, B. Sallee, Eddy Hsi Chun Wang, F. Sansaricq, Nhan Nguyen
Journal of the American Academy of Dermatology. 2021-03-01 - 40 citationsHigh-throughput T cell receptor sequencing identifies clonally expanded CD8 + T cell populations in alopecia areataAnnemieke de Jong, Ali Jabbari, Z. Dai, Luzhou Xing, Dustin Lee
JCI Insight. 2018-10-04
Press Mentions
- Cure for Hair Loss Has Finally Been FoundSeptember 26th, 2016
- FDA-Approved Drug Restores Hair in Patients with Alopecia AreataAugust 18th, 2014
- Alopecia Patients in Study Grow Hair with New DrugAugust 17th, 2014
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: